Agile Therapeutics Inc (AGRX)
0.4003
+0.03
(+8.19%)
USD |
OTCM |
Apr 24, 15:57
Agile Therapeutics Shareholders Equity (Quarterly): -16.32M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.32M |
| September 30, 2023 | -12.41M |
| June 30, 2023 | -12.12M |
| March 31, 2023 | -9.434M |
| December 31, 2022 | -5.545M |
| September 30, 2022 | 6.26M |
| June 30, 2022 | 3.419M |
| March 31, 2022 | 2.743M |
| December 31, 2021 | 3.915M |
| September 30, 2021 | 10.68M |
| June 30, 2021 | 24.61M |
| March 31, 2021 | 35.05M |
| December 31, 2020 | 49.33M |
| September 30, 2020 | 66.13M |
| June 30, 2020 | 80.80M |
| March 31, 2020 | 90.61M |
| December 31, 2019 | 45.74M |
| September 30, 2019 | 31.90M |
| June 30, 2019 | 23.06M |
| March 31, 2019 | 24.66M |
| December 31, 2018 | 20.17M |
| Date | Value |
|---|---|
| September 30, 2018 | 23.18M |
| June 30, 2018 | 26.25M |
| March 31, 2018 | 30.61M |
| December 31, 2017 | 36.32M |
| September 30, 2017 | 41.56M |
| June 30, 2017 | 29.14M |
| March 31, 2017 | 35.61M |
| December 31, 2016 | 42.29M |
| September 30, 2016 | 46.67M |
| June 30, 2016 | 53.52M |
| March 31, 2016 | 60.98M |
| December 31, 2015 | 29.74M |
| September 30, 2015 | 32.75M |
| June 30, 2015 | 41.18M |
| March 31, 2015 | 48.76M |
| December 31, 2014 | 36.01M |
| September 30, 2014 | 42.38M |
| June 30, 2014 | 48.35M |
| March 31, 2014 | -70.29M |
| December 31, 2013 | -71.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.32M
Minimum
Dec 2023
90.61M
Maximum
Mar 2020
22.02M
Average
10.68M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Altimmune Inc | 194.10M |
| iBio Inc | 9.197M |
| Verastem Inc | 57.37M |
| Oragenics Inc | 3.168M |
| Actinium Pharmaceuticals Inc | 36.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.26M |
| Total Liabilities (Quarterly) | 26.57M |
| Debt to Equity Ratio | -0.1045 |
| Current Ratio | 0.4587 |
| Net Debt Paydown Yield | -1.34% |